Carregant...
SA12. Baseline Demographics and Clinical Characteristics From a Prospective, Randomized, Open-Label Study of Paliperidone Palmitate Long-Acting Injection in Subjects With Recent-Onset Schizophrenia or Schizophreniform Disorder
Background: The early, effective treatment of schizophrenia may slow disease progression and improve overall patient outcomes. The DREaM study (NCT02431702) is a doubly randomized, matched-control, open-label, flexible-dose study designed to compare the efficacy of treatment with paliperidone palmit...
Guardat en:
| Publicat a: | Schizophr Bull |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475902/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbx023.011 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|